	Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk. Breast Cancer Res Treat Comeaux JG, Gutierrez N, Ricker CN, Nie Q, Nguyen A, Garcia I, Chang EY, Waggoner RM, Groshen S, Lerman C, Spicer D, Culver JO. PMID: 42430009 [PubMed - indexed for MEDLINE]
	Retinoic acid disrupts cumulus granulosa cells function via EGFR downregulation: induction of PCOS and infertility in adult female mice. Histochem Cell Biol Said A, Marzouk M, Mahmoud A, Emad M, Elkhbery M, Alwutayd KM, Alkhateeb MA, Aldawsari MA, Shokry AE, AbdElkhalek AS. PMID: 42429978 [PubMed - indexed for MEDLINE]
	EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study. Breast Cancer Res Treat Martins-Branco D, Lobo-Martins S, Aftimos P, Pereira B, Vasconcelos de Matos L, Fernandes L, Campôa E, Nader-Marta G, Moreau M, Taylor D, Duhoux FP, Simões P, Garcia AR, Patel V, Confente C, Alpuim Costa D, Pereira J, Santos C, Paesmans M, Sarmento F, Gantes Padrão T, Simão D, Bandarra D, Sousa B, Brito M, Gombos A, Ameye L, de Azambuja E. PMID: 42429895 [PubMed - in process]
	Impact of trop-2 expression on the efficacy of trop-2-targeted antibody-drug conjugates in metastatic breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst Buonaiuto R, Pagliuca M, Longobardi A, Cataldo ML, Arecco L, Gerosa R, Gentile G, Caltavituro A, Barone I, Karakose B, Agostinetto E, Sotiriou C, De Laurentiis M, De Azambuja E, De Angelis C. PMID: 42429566 [PubMed - as supplied by publisher]
	Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy. Pol J Pathol Kowalewski AM, Szylberg . PMID: 42429424 [PubMed - indexed for MEDLINE]
	New and emerging entities ofÂ uterine mesenchymal tumours in theÂ era ofÂ molecular testing. Pol J Pathol Dundr P, Kendall Bárt, Hojný J, Mat, N. PMID: 42429422 [PubMed - indexed for MEDLINE]
	Breast Cancer Presentation, Treatment Patterns, and Progression-Free Survival at a Tertiary Oncology Centre in Bangladesh: A Retrospective Study. Cancer Rep (Hoboken) Chowdhury Q, Rahman MA, Begum FA, Shiddika A, Nurunnabi M, Rupa SA, Parvez M, Begum SMKN, Sultana S. PMID: 42429366 [PubMed - in process]
	Combined Contrast Enhanced Mammography and Digital Breast Tomosynthesis in Patients Suspected of Having Breast Cancer: A Prospective Comparison With Digital Mammography and Breast MRI-Findings of the CONTEST Study. J Med Imaging Radiat Oncol Savaridas SL, Ali K, Vinnicombe S, Rauchhaus P, Evans AJ, Sharma N, Bolt S, Whelehan P. PMID: 42429012 [PubMed - as supplied by publisher]
	Effectiveness of a Smartphone-Based Self-Management App (BeHealth app) for Women with Breast Cancer: A Randomized Controlled Trial. Iran J Public Health Kim HS, Kim HJ. PMID: 42428742 [PubMed]
	Cost-effectiveness analysis of pyrotinib combined with trastuzumab and docetaxel as first-line treatment for HER2-positive metastatic breast cancer in China. Front Pharmacol Liang M, Liu S, Zhang X, Liu Q. PMID: 42428506 [PubMed]
	Treatment of recurrent low grade serous ovarian cancer: MEK inhibition and the RAMP 201 trial. Gynecol Pelvic Med Ali M, Brooks R. PMID: 42428456 [PubMed]
	Uterine fibroids reduce the sensitivity of ultrasound to detect endometrioid and serous endometrial cancer: a retrospective cohort study. Gynecol Pelvic Med Najor AJ, Aspir TB, Fife AJ, Tagoe UJ, Hussein NM, Moran ST, Grant KR, Isani SS, Cowan MW, Nevadunsky NS, Rotenberg OD, Lin KY. PMID: 42428452 [PubMed]
	Cytopathological Findings of Axillary Lymph Nodes in Patients with Breast Cancer in Correlation with Ultrasound Findings. Iran J Pathol Almukhtar ZK, Kareem NM, Abduljabbar ST, Mohsein OA. PMID: 42428342 [PubMed]
	The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basal-like and HER2-enriched breast cancer. medRxiv Bernard PS, Chen BE, Gao D, Shepherd LE, Nielsen TO, Varley KE. PMID: 42428078 [PubMed]
	Method development and validation for determination of entinostat in human plasma and its application in breast cancer patients. RSC Adv Li S, Xu Y, Dong J, Qiu Y, Yang Z, Gao X, Gao J, Feng Z, Wang C, Wang M. PMID: 42427409 [PubMed - as supplied by publisher]
	An Integrated Statistical and Machine Learning Approach for Breast Cancer Classification Using Tumor Morphological Features. Biomed Res Int Woudneh AF, Shiferaw NT, Gebrie YF, Nigussie MM, Cherie KT, Gebeyehu FG. PMID: 42427209 [PubMed - indexed for MEDLINE]
	Practice of breast self-examination and its associated factors among women of reproductive age in seven public health facilities in Addis Ababa, Ethiopia: A multi-centre cross-sectional study. Womens Health (Lond) Mohammed AS, Tafese T, Menberu MS, Nigussie Y, Hassen M, Minda Z, Deress GM. PMID: 42427133 [PubMed - indexed for MEDLINE]
	Intake of polyphenols, phenolic acids and lignans associated with lower mortality in women diagnosed with breast cancer. Br J Nutr Silva ER, Kliemann N, Vieira LC, de Souza JS, Copetti CL, Reitz LK, Vieira FK, Di Pietro PF. PMID: 42427097 [PubMed - as supplied by publisher]
	Large-scale transcriptome analysis reveals KIF20A as a novel indicator of cisplatin resistance in high-grade serous ovarian cancer. J Ovarian Res Cheng L, Wang X, Zhang J, Cai Q, Meng S, Li J, Yu P, Zhang Y, Wang S, Hao D, Li M, Li H. PMID: 42426841 [PubMed - as supplied by publisher]
	Illness perception of breast cancer among patients receiving treatment in a university teaching hospital, South-west Nigeria: a qualitative phenomenological study. BMC Cancer Esan DT, Onabanjo OD, Rasaq NO, Ramos CG. PMID: 42426653 [PubMed - as supplied by publisher]

Articles 1 - 20 / 331926

Page 1 of 16597



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy